Venetoclax in Combination with Daratumumab and Dexamethasone Elicits Deep, Durable Responses in Patients with t(11;14) Relapsed/Refractory Multiple Myeloma: Updated Analyses of Minimal Residual Disease Negativity in Phase 1/2 Study
- Nizar J Bahlis (Speaker)
- Hang Quach (Co-author)
- Rachid Baz (Co-author)
- Annette Juul Vangsted (Co-author)
- Shir Jing Ho (Co-author)
- Abildgaard, N. (Co-author)
- Jacob P Laubach (Co-author)
- Vincent Ribrag (Co-author)
- Peter M Voorhees (Co-author)
- Xifeng Xifeng Wang (Co-author)
- Orlando Bueno (Co-author)
- Yan Luo (Co-author)
- Jeremy A. Ross (Co-author)
- Jonathan L Kaufman (Co-author)
Activity: Talks and presentations › Conference presentations